HKSE - Delayed Quote
HKD
InSilico Medicine Cayman TopCo (3696.HK)
37.260
+1.260
(+3.50%)
At close: 4:08:13 PM GMT+8
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
45.22M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | 36,093,813 |
| % Change in Institutional Shares Held | 20.22% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Ren (Feng Ph.D.) Director (Executive) |
-- | Direct | -- | Oct 9, 2026 |
| Zavoronkovs (Aleksandrs Ph.D.) Chief Executive Officer |
Acquisition at price 6.22 per share. | Direct | 130,615 | Sep 7, 2026 |
| Zavoronkovs (Aleksandrs Ph.D.) Chief Executive Officer |
Acquisition at price 6.25 per share. | Direct | 577,921 | Sep 4, 2026 |
| Ren (Feng Ph.D.) Director (Executive) |
-- | Direct | -- | Jul 6, 2026 |
| Ren (Feng Ph.D.) Director (Executive) |
-- | Direct | -- | Jun 30, 2026 |
